Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Moles”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06291753
What this trial is testing

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

Who this might be right for
Primary Malignant Melanoma of the Esophagus
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00070642
What this trial is testing

CPG 7909 Injection in Melanoma

Who this might be right for
Carcinoma, Melanoma
Pfizer 184
Not applicableStudy completedNCT05615883
What this trial is testing

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

Who this might be right for
Melanoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 16
Testing effectiveness (Phase 2)Ended earlyNCT00496223
What this trial is testing

A Phase I/II Study of Sunitinib and Dacarbazine

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Not applicableLooking for participantsNCT07422779
What this trial is testing

Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia

Who this might be right for
Metastatic MelanomaSkin Cancer
Institute of Oncology Ljubljana 100
Testing effectiveness (Phase 2)Ended earlyNCT02974803
What this trial is testing

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Who this might be right for
MelanomaBrain Metastases
Canadian Cancer Trials Group 6
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Early research (Phase 1)Study completedNCT00453050
What this trial is testing

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

Who this might be right for
Melanoma (Skin)Metastatic Cancer
University of Oklahoma 11
Not applicableStudy completedNCT02206360
What this trial is testing

Pancreatic Cancer Early Detection Program

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma+8 more
White Plains Hospital 181
Not applicableUnknownNCT03449615
What this trial is testing

Validation of Ferromagnetic Tracer in Melanoma Sentinel Node

Who this might be right for
Melanoma StageSentinel Lymph Node
Sociedad Española de Oncología Quirúrgica 186
Not applicableUnknownNCT05402059
What this trial is testing

Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

Who this might be right for
MelanomaMelanoma (Skin)Melanoma, Uveal+5 more
MelanomaPRO, Russia 1,570
Testing effectiveness (Phase 2)Active Not RecruitingNCT03757689
What this trial is testing

Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma

Who this might be right for
Melanoma
Abramson Cancer Center at Penn Medicine 63
Not applicableUnknownNCT03683550
What this trial is testing

Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma

Who this might be right for
Melanoma
University Hospital, Essen 836
Not applicableAvailableNCT04960891
What this trial is testing

A Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp

Who this might be right for
Uveal Melanoma
Immunocore Ltd
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06470880
What this trial is testing

Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy

Who this might be right for
Melanoma
The Christie NHS Foundation Trust 40
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT01064713
What this trial is testing

Phase II Study of Tesetaxel in Metastatic Melanoma

Who this might be right for
Advanced MelanomaCancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)UnknownNCT04021420
What this trial is testing

Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma

Who this might be right for
MelanomaMetastatic Melanoma
Assistance Publique - Hôpitaux de Paris 21
Next Page